A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience)
2000 ◽
Vol 7
(8)
◽
pp. 588-592
◽
Jeffery P. Lamont
◽
John Nemunaitis
◽
Joseph A. Kuhn
◽
Steven A. Landers
◽
Todd M. McCarty